Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Csernok

Showing results (61-70 of 107) with videos related to

Pageof 11
Sort By:
Scandinavian Journal of Rheumatology|October 12, 2000
BPI-ANCA is found in reactive arthritis caused by Yersinia and Salmonella infection and recognise exclusively the C-terminal part of the BPI moleculeH Schultz, E Csernok, S Nikkari, et al.
The American Journal of Medicine|June 1, 1997
High plasma levels of the soluble form of CD30 activation molecule reflect disease activity in patients with Wegener's granulomatosisG Wang, H Hansen, E Tatsis, et al.
Journal of Immunological Methods|July 14, 1997
Use of native and recombinant bactericidal/permeability-increasing proteins (BPI) as antigens for detection of BPI-ANCAH Schultz, E Csernok, T W Johnston, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Membrane surface proteinase 3 expression and intracytoplasmic immunoglobulin on neutrophils from patients with ANCA-associated vasculitidesE Csernok, W H Schmitt, M Ernst, et al.
Arthritis and Rheumatism|March 7, 2001
Elevated interleukin-4 and interleukin-13 production by T cell lines from patients with Churg-Strauss syndromeM Kiene, E Csernok, A Müller, et al.
Rheumatology (Oxford, England)|June 15, 2000
Anticardiolipin antibodies and antibodies to beta(2)-glycoprotein I in patients with Wegener's granulomatosisP Lamprecht, K deGroot, A Schnabel, et al.
International Journal of Immunogenetics|February 3, 2005
Association study of Wegener granulomatosis and the functionally relevant A645G polymorphism in the bactericidal/permeability increasing protein (BPI) geneP Jagiello, W Klein, H Schultz, et al.
Annals of the Rheumatic Diseases|June 15, 2010
Serum HMGB1 levels are increased in active Wegener's granulomatosis and differentiate between active forms of ANCA-associated vasculitisD Wibisono, E Csernok, P Lamprecht, et al.
Cytokine|May 11, 2000
Neutrophils synthesize and activate TGFbeta2C H Szymkowiak, E Csernok, D Reinhold, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|July 13, 2000
Anti-neutrophil cytoplasmic antibodies directed against the bactericidal/permeability-increasing protein (BPI) in pediatric cystic fibrosis patients do not recognize N-terminal regions important for the anti-microbial and lipopolysaccharide-binding activity of BPIH Schultz, E Csernok, A Schuster, et al.
Pageof 11

Showing results (61-70 of 107) with videos related to

Sort By:
Pageof 11
Scandinavian Journal of Rheumatology|October 12, 2000
BPI-ANCA is found in reactive arthritis caused by Yersinia and Salmonella infection and recognise exclusively the C-terminal part of the BPI moleculeH Schultz, E Csernok, S Nikkari, et al.
The American Journal of Medicine|June 1, 1997
High plasma levels of the soluble form of CD30 activation molecule reflect disease activity in patients with Wegener's granulomatosisG Wang, H Hansen, E Tatsis, et al.
Journal of Immunological Methods|July 14, 1997
Use of native and recombinant bactericidal/permeability-increasing proteins (BPI) as antigens for detection of BPI-ANCAH Schultz, E Csernok, T W Johnston, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Membrane surface proteinase 3 expression and intracytoplasmic immunoglobulin on neutrophils from patients with ANCA-associated vasculitidesE Csernok, W H Schmitt, M Ernst, et al.
Arthritis and Rheumatism|March 7, 2001
Elevated interleukin-4 and interleukin-13 production by T cell lines from patients with Churg-Strauss syndromeM Kiene, E Csernok, A Müller, et al.
Rheumatology (Oxford, England)|June 15, 2000
Anticardiolipin antibodies and antibodies to beta(2)-glycoprotein I in patients with Wegener's granulomatosisP Lamprecht, K deGroot, A Schnabel, et al.
International Journal of Immunogenetics|February 3, 2005
Association study of Wegener granulomatosis and the functionally relevant A645G polymorphism in the bactericidal/permeability increasing protein (BPI) geneP Jagiello, W Klein, H Schultz, et al.
Annals of the Rheumatic Diseases|June 15, 2010
Serum HMGB1 levels are increased in active Wegener's granulomatosis and differentiate between active forms of ANCA-associated vasculitisD Wibisono, E Csernok, P Lamprecht, et al.
Cytokine|May 11, 2000
Neutrophils synthesize and activate TGFbeta2C H Szymkowiak, E Csernok, D Reinhold, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|July 13, 2000
Anti-neutrophil cytoplasmic antibodies directed against the bactericidal/permeability-increasing protein (BPI) in pediatric cystic fibrosis patients do not recognize N-terminal regions important for the anti-microbial and lipopolysaccharide-binding activity of BPIH Schultz, E Csernok, A Schuster, et al.
Pageof 11